The U.S. Food and Drug Administration is warning transvaginal mesh products, a mainstay of pelvic organ prolapse repair, carries a high risk for adverse events and as result the mesh will now carry a class III warning. Via MedPage Today. Posted January 4, 2016.
–Alanna McCatty
